![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Zacks Analyst Blog Highlights: Amylin Pharmaceuticals, Merck, Glaxo, Bristol and Eli Lilly. – Press Releases
Zacks Market Commentaries (June 9th, 2009) Writes:
Chicago, IL - June 9, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amylin Pharmaceuticals (AMLN), Merck (MRK), Glaxo (GSK), Bristol (BMY) and Eli Lilly (LLY).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.
Here are highlights from Monday's Analyst Blog:
Amylin Update Post ADA Meeting
This past weekend, Amylin Pharmaceuticals (AMLN) presented several abstracts and oral presentations at the American Diabetes Association (ADA) meeting in New Orleans. At the meeting, Amylin presented long-term follow-up data from the 74-week open label portion of the DURATION-1 program that demonstrated
...American Diabetes Association;, Amylin Pharmaceuticals;, analog, Blog, Bristol, Byetta, Carcinoma, Chicago, Diabetes, Eli Lilly, Fda, Glaxo;, GLP-1;, Leonard Zacks;, March;, Market Commentary, Merck, New Orleans, pancreatitis, Stocks to Watch, Zacks, Zacks Investment Research Inc.;, Zacks Market Commentaries
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.